These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25503658)

  • 21. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.
    Kang SJ; Mintz GS; Akasaka T; Park DW; Lee JY; Kim WJ; Lee SW; Kim YH; Whan Lee C; Park SW; Park SJ
    Circulation; 2011 Jun; 123(25):2954-63. PubMed ID: 21646494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.
    Granata F; Attizzani GF; Tartaglione D; Cappelli Bigazzi M; Bianchi R; Varricchio A; Russo MG; Calabrò P
    Int J Cardiol; 2015 Nov; 199():221-2. PubMed ID: 26209822
    [No Abstract]   [Full Text] [Related]  

  • 24. Very late stent thrombosis after sirolimus-eluting stent implantation observed using optical coherence tomography and coronary angioscopy.
    Ikenaga H; Dai K; Ishihara M
    J Invasive Cardiol; 2010 Nov; 22(11):557-8. PubMed ID: 21041855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.
    Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Yamaji K; Ando K; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Tamura T; Shirotani M; Miki S; Matsuda M; Takahashi M; Ishii K; Tanaka M; Aoyama T; Doi O; Hattori R; Kato M; Suwa S; Takizawa A; Takatsu Y; Shinoda E; Eizawa H; Takeda T; Lee JD; Inoko M; Ogawa H; Hamasaki S; Horie M; Nohara R; Kambara H; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Circ Cardiovasc Interv; 2014 Apr; 7(2):168-79. PubMed ID: 24550439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Matsuo Y; Kubo T; Aoki H; Satogami K; Ino Y; Kitabata H; Taruya A; Nishiguchi T; Teraguchi I; Shimamura K; Shiono Y; Orii M; Yamano T; Tanimoto T; Yamaguchi T; Hirata K; Tanaka A; Akasaka T
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E9-E14. PubMed ID: 26268150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical coherence tomography patterns of stent restenosis.
    Gonzalo N; Serruys PW; Okamura T; van Beusekom HM; Garcia-Garcia HM; van Soest G; van der Giessen W; Regar E
    Am Heart J; 2009 Aug; 158(2):284-93. PubMed ID: 19619707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation.
    Im E; Kim BK; Ko YG; Shin DH; Kim JS; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2014 Feb; 7(1):88-96. PubMed ID: 24425586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation.
    Yoneda S; Abe S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Coron Artery Dis; 2013 Aug; 24(5):368-73. PubMed ID: 23744617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
    Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
    JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
    [No Abstract]   [Full Text] [Related]  

  • 31. First report of a novel polymer-free dual-drug eluting stent in de novo coronary artery disease: results of the first in human BICARE trial.
    Yu M; Xu B; Kandzari DE; Wu Y; Yan H; Chen J; Qian J; Qiao S; Yang Y; Gao RL
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):405-11. PubMed ID: 23857821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation.
    Radu MD; Räber L; Heo J; Gogas BD; Jørgensen E; Kelbæk H; Muramatsu T; Farooq V; Helqvist S; Garcia-Garcia HM; Windecker S; Saunamäki K; Serruys PW
    EuroIntervention; 2014 Jan; 9(9):1085-94. PubMed ID: 24064426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography.
    Goto K; Takebayashi H; Kihara Y; Hagikura A; Fujiwara Y; Kikuta Y; Sato K; Kodama S; Taniguchi M; Hiramatsu S; Haruta S
    EuroIntervention; 2013 Sep; 9(5):601-7. PubMed ID: 23518860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography assessment of in-stent restenosis after percutaneous coronary intervention with two-stent technique in unprotected left main.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Warisawa T; Watanabe Y; Mitomo S; Sato T; Kurita N; Ishiguro H; Hozawa K; Nakamura S; Bezerra HG; Nakamura S
    Int J Cardiol; 2016 Sep; 219():285-92. PubMed ID: 27343422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).
    Picchi A; Musumeci G; Calabria P; Cresti A; Rescigno R; Aruffo A; Prati F; Limbruno U
    Am J Cardiol; 2015 May; 115(10):1351-6. PubMed ID: 25772742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
    Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
    EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.